<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK47079" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK47079/" /><meta name="ncbi_pagename" content="Kleefstra Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Kleefstra Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Kleefstra Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/03/21" /><meta name="citation_author" content="Tjitske Kleefstra" /><meta name="citation_author" content="Nicole de Leeuw" /><meta name="citation_pmid" content="20945554" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK47079/" /><meta name="citation_keywords" content="9q Subtelomeric Deletion Syndrome" /><meta name="citation_keywords" content="9q34.3 Microdeletion Syndrome" /><meta name="citation_keywords" content="9qSTDS" /><meta name="citation_keywords" content="9q Subtelomeric Deletion Syndrome" /><meta name="citation_keywords" content="9qSTDS" /><meta name="citation_keywords" content="9q34.3 Microdeletion Syndrome" /><meta name="citation_keywords" content="Histone-lysine N-methyltransferase EHMT1" /><meta name="citation_keywords" content="EHMT1" /><meta name="citation_keywords" content="Kleefstra Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Kleefstra Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Tjitske Kleefstra" /><meta name="DC.Contributor" content="Nicole de Leeuw" /><meta name="DC.Date" content="2019/03/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK47079/" /><meta name="description" content="Kleefstra syndrome is characterized by intellectual disability, autistic-like features, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate-to-severe spectrum of intellectual disability although a few individuals have mild delay and total IQ within low-normal range. While most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed; these include heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsy/febrile seizures, psychiatric disorders, and extreme apathy or catatonic-like features after puberty." /><meta name="og:title" content="Kleefstra Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Kleefstra syndrome is characterized by intellectual disability, autistic-like features, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate-to-severe spectrum of intellectual disability although a few individuals have mild delay and total IQ within low-normal range. While most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed; these include heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsy/febrile seizures, psychiatric disorders, and extreme apathy or catatonic-like features after puberty." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK47079/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/kleefstra/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK47079/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BF05CE0418F2100000000004E0022.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK47079_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK47079_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kindler/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mdel17q21_31/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK47079_"><span class="title" itemprop="name">Kleefstra Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: 9q Subtelomeric Deletion Syndrome, 9q34.3 Microdeletion Syndrome, 9qSTDS</div><p class="contrib-group"><span itemprop="author">Tjitske Kleefstra</span>, MD, PhD and <span itemprop="author">Nicole de Leeuw</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK47079_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK47079_ai__"><div class="contrib half_rhythm"><span itemprop="author">Tjitske Kleefstra</span>, MD, PhD<div class="affiliation small">Department of Human Genetics<br />Radboud University Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@artsfeelk.ekstijt" class="oemail">ln.cmuduobdar@artsfeelk.ekstijt</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nicole de Leeuw</span>, PhD<div class="affiliation small">Department of Human Genetics<br />Radboud University Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@wueeled.elocin" class="oemail">ln.cmuduobdar@wueeled.elocin</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 5, 2010</span>; Last Update: <span itemprop="dateModified">March 21, 2019</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="kleefstra.Summary" itemprop="description"><h2 id="_kleefstra_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Kleefstra syndrome is characterized by intellectual disability, autistic-like features, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate-to-severe spectrum of intellectual disability although a few individuals have mild delay and total IQ within low-normal range. While most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed; these include heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsy/febrile seizures, psychiatric disorders, and extreme apathy or catatonic-like features after puberty.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Kleefstra syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 9q34.3 that includes at least part of <i>EHMT1</i> (~50%) or a heterozygous intragenic <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (~50%).</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Ongoing routine care by a multidisciplinary team specializing in the care of children or adults with intellectual disability. Referral to age-appropriate early-childhood intervention programs, special education programs, or vocational training; speech/language therapy, physical and occupational therapy, and sensory integration therapy; specialized care for those with extreme behavior problems, movement disorders, sleep disorders, and/or epilepsy; standard treatment for vision, hearing, cardiac, renal, urologic, and other medical issues.</p><p><i>Surveillance:</i> Monitoring as needed of cardiac and renal/urologic abnormalities.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Kleefstra syndrome, caused by a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at 9q34.3 or pathogenic variants in <i>EHMT1</i>, is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Almost all cases reported to date have been <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>; rarely, recurrence in a family has been reported when a parent has a balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> involving the 9q34.3 region or <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for an interstitial 9q34.3 deletion. Except for individuals with somatic mosaicism for a 9q34.3 deletion, no individuals with Kleefstra syndrome have been known to reproduce. Prenatal testing may be offered to unaffected parents of a child with a 9q34.3 deletion or an <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> because of the increased risk of recurrence associated with the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, somatic mosaicism including the germline, or a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> translocation.</p></div></div><div id="kleefstra.Diagnosis"><h2 id="_kleefstra_Diagnosis_">Diagnosis</h2><p>Kleefstra syndrome is characterized by intellectual disability, childhood hypotonia, and distinctive facial features. A complex pattern of other findings can also be observed [<a class="bk_pop" href="#kleefstra.REF.dawson.2002.488">Dawson et al 2002</a>, <a class="bk_pop" href="#kleefstra.REF.cormierdaire.2003.300">Cormier-Daire et al 2003</a>, <a class="bk_pop" href="#kleefstra.REF.stewart.2004.340">Stewart et al 2004</a>, <a class="bk_pop" href="#kleefstra.REF.kleefstra.2005.299">Kleefstra et al 2005</a>, <a class="bk_pop" href="#kleefstra.REF.yatsenko.2005.328">Yatsenko et al 2005</a>, <a class="bk_pop" href="#kleefstra.REF.kleefstra.2006a.370">Kleefstra et al 2006a</a>, <a class="bk_pop" href="#kleefstra.REF.kleefstra.2006b.618">Kleefstra et al 2006b</a>, <a class="bk_pop" href="#kleefstra.REF.stewart.2007.383">Stewart &#x00026; Kleefstra 2007</a>, <a class="bk_pop" href="#kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</a>, <a class="bk_pop" href="#kleefstra.REF.yatsenko.2009.1924">Yatsenko et al 2009</a>, <a class="bk_pop" href="#kleefstra.REF.willemsen.2012.202">Willemsen et al 2012</a>].</p><div id="kleefstra.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Kleefstra syndrome <b>should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div>Intellectual disability, usually moderate to severe and associated with severe speech delay</div></li><li class="half_rhythm"><div>Distinctive facial features (see <a href="#kleefstra.Clinical_Description">Clinical Description</a>)</div></li><li class="half_rhythm"><div>Childhood hypotonia</div></li><li class="half_rhythm"><div>Visual problems (hypermetropia)</div></li><li class="half_rhythm"><div>Hearing loss (sensorineural and/or conductive)</div></li><li class="half_rhythm"><div>Motor delay</div></li><li class="half_rhythm"><div>Heart defects</div></li><li class="half_rhythm"><div>Renal/urologic defects</div></li><li class="half_rhythm"><div>Genital defects (males)</div></li><li class="half_rhythm"><div>Severe infections (respiratory)</div></li><li class="half_rhythm"><div>Epilepsy/febrile seizures</div></li><li class="half_rhythm"><div>Autism spectrum disorder</div></li><li class="half_rhythm"><div>Psychiatric disorders (mood and psychotic disorders)</div></li><li class="half_rhythm"><div>Extreme apathy or catatonic(-like) features post puberty</div></li><li class="half_rhythm"><div>Nonspecific brain abnormalities: structural defects (corpus callosum hypoplasia), cortical hypoplasia, or white matter defects</div></li></ul></div><div id="kleefstra.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Kleefstra syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has one of the following on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK47079/table/kleefstra.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figkleefstraTmoleculargenetictestingus" rid-ob="figobkleefstraTmoleculargenetictestingus">Table 1</a>):</p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 9q34.3 (~50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [Author, personal experience]. In 28 unrelated individuals with a 9q34.3 deletion, three distinct categories were identified [<a class="bk_pop" href="#kleefstra.REF.yatsenko.2009.1924">Yatsenko et al 2009</a>]:</div><ul><li class="half_rhythm"><div>50% bona fide <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> terminal deletions</div></li><li class="half_rhythm"><div>25% interstitial deletions</div></li><li class="half_rhythm"><div>25% complex rearrangements or derivative chromosomes</div></li></ul></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> involving <i>EHMT1</i> (~50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals)</div></li></ul><p>When the phenotypic findings suggest the diagnosis of Kleefstra syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA)</b>, <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and, rarely, <b><a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a></b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Chromosomal microarray analysis (CMA)</b> uses SNP and/or oligonucleotide arrays to detect genome-wide large deletions/duplications (including <i>EHMT1</i>) that cannot be detected by typical <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>EHMT1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm">Approximately 5% of individuals with Kleefstra syndrome have an intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> detectable by an assay designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications (e.g., multiplex ligation-dependent probe amplification [MLPA], qPCR, and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted CMA). Deletions that are not intragenic but too small to be detected by CMA (e.g., containing the last part of <i>C90RF37</i> and the first exon of <i>EHMT1</i>) require such gene-targeted methods designed for this region for detection.</div><div class="half_rhythm">Note: (1) <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> cannot reliably detect deletions &#x0003c;50-100 kb and cannot routinely size the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>. (2) The 9q34.3 deletion cannot be identified by routine <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> analysis.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>An intellectual disability <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>EHMT1</i> and other genes of interest (see <a href="#kleefstra.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK47079/table/kleefstra.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figkleefstraTmoleculargenetictestingus" rid-ob="figobkleefstraTmoleculargenetictestingus">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Karyotype.</b> In rare instances, Kleefstra syndrome can be caused by a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement that disrupts the expression of <i>EHMT1</i>. If this is suspected, <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> and <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis for the 9q34.3 region can be considered. However, the typical 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> cannot be identified by routine chromosome analysis.</div></li></ul><div id="kleefstra.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Kleefstra Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47079/table/kleefstra.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kleefstra.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>EHMT1</i></td><td headers="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>3</sup></td><td headers="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~50%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~50%</td></tr><tr><td headers="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 7</td></tr><tr><td headers="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">Karyotype</td><td headers="hd_h_kleefstra.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rare; see footnote 8</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="kleefstra.TF.1.1"><p class="no_margin">See <a href="/books/NBK47079/#kleefstra.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="kleefstra.TF.1.2"><p class="no_margin">See <a href="#kleefstra.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="kleefstra.TF.1.3"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes probe coverage of <i>EHMT1</i> can detect deletions of 9q34.3 (<a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> terminal deletions, complex rearrangements or derivative chromosomes, interstitial <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>).</p></div></dd><dt>4. </dt><dd><div id="kleefstra.TF.1.4"><p class="no_margin">CMA testing is appropriate to define breakpoints of large deletions; however, intragenic deletions in <i>EHMT1</i> may not be detected by this method.</p></div></dd><dt>5. </dt><dd><div id="kleefstra.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="kleefstra.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="kleefstra.TF.1.7"><p class="no_margin">Gene-targeted methods will detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> up to whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions; however, breakpoints of large deletions and/or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of adjacent genes may not be determined. Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>EHMT1</i> may detect an additional ~5% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have had a normal <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a>, but this is highly dependent on the resolution and probe coverage of the array platform that was used for analysis.</p></div></dd><dt>8. </dt><dd><div id="kleefstra.TF.1.8"><p class="no_margin">Routine <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> will not detect the 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>. Karyotype may be considered in those with features of Kleefstra syndrome in whom a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (mutation or deletion) of <i>EHMT1</i> has not been identified using other methods (e.g., CMA, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>). Karyotype can detect balanced chromosomal rearrangements that disrupt <i>EHMT1</i>.</p></div></dd></dl></div></div></div></div></div><div id="kleefstra.Clinical_Characteristics"><h2 id="_kleefstra_Clinical_Characteristics_">Clinical Characteristics</h2><div id="kleefstra.Clinical_Description"><h3>Clinical Description</h3><p>Kleefstra syndrome has a clinically recognizable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that includes physical, developmental, and behavioral features. Males and females are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> equally [<a class="bk_pop" href="#kleefstra.REF.stewart.2004.340">Stewart et al 2004</a>, <a class="bk_pop" href="#kleefstra.REF.yatsenko.2005.328">Yatsenko et al 2005</a>, <a class="bk_pop" href="#kleefstra.REF.kleefstra.2006b.618">Kleefstra et al 2006b</a>, <a class="bk_pop" href="#kleefstra.REF.stewart.2007.383">Stewart &#x00026; Kleefstra 2007</a>, <a class="bk_pop" href="#kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</a>, <a class="bk_pop" href="#kleefstra.REF.willemsen.2012.202">Willemsen et al 2012</a>].</p><p>Birth weight is usually within the normal or above-normal range; weight increases in childhood, leading to obesity (50%) [<a class="bk_pop" href="#kleefstra.REF.cormierdaire.2003.300">Cormier-Daire et al 2003</a>, <a class="bk_pop" href="#kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</a>, <a class="bk_pop" href="#kleefstra.REF.willemsen.2012.202">Willemsen et al 2012</a>]. The facial appearance is characterized by brachy(-micro)cephaly, broad forehead, unusual shape of eyebrows (arched or straight with synophrys), mildly upslanted palpebral fissures, midface retrusion, thickened ear helices, short nose with anteverted nares, fleshy everted vermilion of the lower lip and exaggerated cupid's bow or "tented" appearance of the vermilion of the upper lip, and protruding tongue and relative prognathism (<a class="figpopup" href="/books/NBK47079/figure/kleefstra.F1/?report=objectonly" target="object" rid-figpopup="figkleefstraF1" rid-ob="figobkleefstraF1">Figure 1</a>, <a class="figpopup" href="/books/NBK47079/figure/kleefstra.F2/?report=objectonly" target="object" rid-figpopup="figkleefstraF2" rid-ob="figobkleefstraF2">Figure 2</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figkleefstraF1" co-legend-rid="figlgndkleefstraF1"><a href="/books/NBK47079/figure/kleefstra.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figkleefstraF1" rid-ob="figobkleefstraF1"><img class="small-thumb" src="/books/NBK47079/bin/kleefstra-Image001.gif" src-large="/books/NBK47079/bin/kleefstra-Image001.jpg" alt="Figure 1. . Photographs of affected individuals showing the characteristic facial profile comprising brachycephaly, widely spaced eyes, synophrys/arched eyebrows, midface retrusion, protruding tongue, eversion of the vermilion of the lower lip, and prognathism of chin." /></a><div class="icnblk_cntnt" id="figlgndkleefstraF1"><h4 id="kleefstra.F1"><a href="/books/NBK47079/figure/kleefstra.F1/?report=objectonly" target="object" rid-ob="figobkleefstraF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Photographs of affected individuals showing the characteristic facial profile comprising brachycephaly, widely spaced eyes, synophrys/arched eyebrows, midface retrusion, protruding tongue, eversion of the vermilion of the lower lip, and prognathism of <a href="/books/NBK47079/figure/kleefstra.F1/?report=objectonly" target="object" rid-ob="figobkleefstraF1">(more...)</a></p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figkleefstraF2" co-legend-rid="figlgndkleefstraF2"><a href="/books/NBK47079/figure/kleefstra.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figkleefstraF2" rid-ob="figobkleefstraF2"><img class="small-thumb" src="/books/NBK47079/bin/kleefstra-Image002.gif" src-large="/books/NBK47079/bin/kleefstra-Image002.jpg" alt="Figure 2. . Photographs of affected individuals showing the characteristic facial profile comprising brachycephaly, widely spaced eyes, synophrys/arched eyebrows, midface retrusion, protruding tongue, eversion of the vermilion of the lower lip, and prognathism of the chin." /></a><div class="icnblk_cntnt" id="figlgndkleefstraF2"><h4 id="kleefstra.F2"><a href="/books/NBK47079/figure/kleefstra.F2/?report=objectonly" target="object" rid-ob="figobkleefstraF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Photographs of affected individuals showing the characteristic facial profile comprising brachycephaly, widely spaced eyes, synophrys/arched eyebrows, midface retrusion, protruding tongue, eversion of the vermilion of the lower lip, and prognathism of <a href="/books/NBK47079/figure/kleefstra.F2/?report=objectonly" target="object" rid-ob="figobkleefstraF2">(more...)</a></p></div></div><p>With age, the facial appearance becomes coarser, with persisting midface retrusion and prognathism. An increased frequency of dental anomalies, specifically neonatal teeth and retention of primary dentition, has been observed.</p><p><b>Cognitive development.</b> Individuals with Kleefstra syndrome exhibit a range of cognitive and adaptive functioning [<a class="bk_pop" href="#kleefstra.REF.vermeulen.2017a.1821">Vermeulen et al 2017a</a>]. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals function in the moderate-to-severe spectrum of intellectual disability, although a few individuals with only mild delay are known. Rarely, individuals with normal total IQ levels who have a diagnosis of an autism spectrum disorder have been described [<a class="bk_pop" href="#kleefstra.REF.bock.2016.131">Bock et al 2016</a>; Author, personal observation]. Most affected individuals have severe expressive speech delay with hardly any speech development, whereas general language development is usually at a higher level; thus, sign language or use of pictograms is of value to many affected individuals.</p><p><b>Behavior.</b> Besides issues with social behavior, the behavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> includes sleep disturbances, stereotypies, mild self-injurious behaviors, and autism spectrum disorder usually recognized in early childhood. A few reports of adolescents and adults revealed extreme, progressive apathy and catatonic(-like) behavior [<a class="bk_pop" href="#kleefstra.REF.verhoeven.2010.536">Verhoeven et al 2010</a>, <a class="bk_pop" href="#kleefstra.REF.vermeulen.2017a.1821">Vermeulen et al 2017a</a>, <a class="bk_pop" href="#kleefstra.REF.vermeulen.2017b.185">Vermeulen et al 2017b</a>].</p><ul><li class="half_rhythm"><div>Sleep disturbance is characterized by frequent nocturnal and early-morning awakenings as well as excessive daytime wakefulness &#x02013; in contrast to the sleep disturbance observed in <a href="/books/n/gene/sms/">Smith-Magenis syndrome</a>.</div></li><li class="half_rhythm"><div>Sleep disturbance in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adolescents and young adults may be a precursor to severe regression, as well as the later development of psychoses, for which treatment is recommended.</div></li></ul><p><b>Motor development</b> is impaired by childhood hypotonia, but almost all individuals achieve independent walking after age two to three years.</p><p><b>Hearing and vision impairment</b>. A substantial proportion of individuals have hypermetropia at a young age. Hearing impairment (both conductive and sensorineuronal) may also be present starting at a young age.</p><p><b>Congenital heart defects</b> are observed in a significant number of individuals with Kleefstra syndrome. In 50% a (conotruncal) heart defect is present. Abnormalities that have been reported include ASD/VSD, tetralogy of Fallot, aortic coarctation, bicuspid aortic valve, and pulmonic stenosis. Atrial flutter has been reported in a number of individuals.</p><p><b>Genitourinary anomalies.</b> Renal defects, seen in 10%-30% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, comprise vesicoureteral reflux, hydronephrosis, renal cysts, and chronic renal insufficiency. Genital defects such as hypospadias, cryptorchidism, and small penis are reported in 30% of males.</p><p><b>Seizures,</b> reported in 30%, can include tonic-clonic seizures, absence seizures, and complex partial epilepsy.</p><p><b>Other.</b> Several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have had talipes equinovarus. Other abnormalities that have been observed are epigastric hernia, tracheo-/bronchomalacia with respiratory insufficiency, and gastroesophageal reflux.</p><p><b>Life expectancy.</b> Longitudinal data are insufficient to determine life expectancy; however, it should be noted that death in infancy or childhood can occur from complications such as heart defects and recurrent aspiration and pulmonary infections [<a class="bk_pop" href="#kleefstra.REF.stewart.2007.383">Stewart &#x00026; Kleefstra 2007</a>].</p></div><div id="kleefstra.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><i>EHMT1</i> loss of function accounts for the majority of features in Kleefstra syndrome. Current data indicate that individuals with an intragenic <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (e.g., a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, frameshift, or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant) and those with a small (&#x0003c;1-Mb) 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have similar clinical findings. Individuals with larger deletions (&#x02265;1 Mb), however, generally have more severe intellectual disability and more medical problems, such as <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies, feeding problems, and respiratory problems. Pulmonary infections and aspiration difficulties in particular appear to be more severe in individuals with larger 9q34 deletions than in those with smaller deletions or intragenic <i>EHMT1</i> pathogenic variants.</p></div><div id="kleefstra.Nomenclature"><h3>Nomenclature</h3><p>The disorder was first recognized following widespread subtelomeric <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> studies [<a class="bk_pop" href="#kleefstra.REF.knight.1999.1676">Knight et al 1999</a>, <a class="bk_pop" href="#kleefstra.REF.dawson.2002.488">Dawson et al 2002</a>]. After the identification of an individual with a similar <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> disrupting <i>EHMT1</i>, it was hypothesized that <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> caused the phenotype present in individuals with a 9q34 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#kleefstra.REF.kleefstra.2005.299">Kleefstra et al 2005</a>]. Subsequent identification of additional individuals with intragenic <i>EHMT1</i> defects led OMIM to assign the name Kleefstra to the syndrome.</p></div><div id="kleefstra.Prevalence"><h3>Prevalence</h3><p>Reliable figures on <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> are not yet available. Based on data from other rare disorders involving intellectual disability [<a class="bk_pop" href="#kleefstra.REF.mcrae.2017.433">McRae et al 2017</a>], Kleefstra syndrome is estimated to affect at least 1:120,000 individuals who have a neurodevelopmental disorder [Author, personal observation]; as many individuals with this condition are not diagnosed, the true prevalence may be much higher.</p><p>The syndrome has been identified worldwide and in all ethnic groups.</p></div></div><div id="kleefstra.Genetically_Related_Allelic_Di"><h2 id="_kleefstra_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in the genes located within the 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a> or with pathogenic variants in <i>EHMT1</i>.</p></div><div id="kleefstra.Differential_Diagnosis"><h2 id="_kleefstra_Differential_Diagnosis_">Differential Diagnosis</h2><p>Kleefstra syndrome should be distinguished from other syndromes that include developmental delay, infantile hypotonia, short stature, distinctive facies, and a behavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. The most common of these include those in <a class="figpopup" href="/books/NBK47079/table/kleefstra.T.disorders_to_consider_in_the/?report=objectonly" target="object" rid-figpopup="figkleefstraTdisorderstoconsiderinthe" rid-ob="figobkleefstraTdisorderstoconsiderinthe">Table 2</a>, which can be distinguished using <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> (<a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>) and/or molecular analysis.</p><div id="kleefstra.T.disorders_to_consider_in_the" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Kleefstra Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47079/table/kleefstra.T.disorders_to_consider_in_the/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kleefstra.T.disorders_to_consider_in_the_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene / Genetic<br />Mechanism</th><th id="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Additional Overlapping Clinical Features</th></tr></thead><tbody><tr><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Down syndrome</td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Trisomy 21</td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Virtually all <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Similar facial characteristics, incl:
<ul><li class="half_rhythm"><div>Brachycephaly</div></li><li class="half_rhythm"><div>Protruding tongue</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Midface retrusion</div></li></ul>
</td></tr><tr><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sms/">Smith-Magenis syndrome</a></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion or mutation of <i>RAI1</i> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 17p11.2&#x000a0;<sup>1</sup></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Virtually all <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Lethargy</div></li><li class="half_rhythm"><div>Sleep disturbance</div></li><li class="half_rhythm"><div>Midface retrusion</div></li></ul>
</td></tr><tr><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pitt-hopkins/">Pitt-Hopkins syndrome</a></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Haploinsufficiency of <i>TCF4</i></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Most <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Speech is significantly delayed &#x00026; most individuals are nonverbal w/receptive language often stronger than expressive language.</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Sleep disturbance</div></li></ul>
</td></tr><tr><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/angelman/">Angelman syndrome</a></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disruption of maternally <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> <i>UBE3A</i></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Receptive language better than expressive language skills</div></li><li class="half_rhythm"><div>Sleep disturbances w/multiple awakenings</div></li><li class="half_rhythm"><div>Midface retrusion w/prognathism</div></li><li class="half_rhythm"><div>See footnote 3 for distinguishing clinical features.</div></li></ul>
</td></tr><tr><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KMT2C</i>-associated syndrome&#x000a0;<sup>4</sup></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KMT2C</i></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Currently under study to determine overlap</div></li><li class="half_rhythm"><div>ASD &#x00026; ID</div></li></ul>
</td></tr><tr><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mbd5-dis/"><i>MBD5 </i>haploinsufficiency</a></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 5</td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD; typically <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a></td><td headers="hd_h_kleefstra.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>ASD &#x00026; ID</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Developmental regression</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; ASD = autism spectrum disorder; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="kleefstra.TF.2.1"><p class="no_margin">Approximately 95% of individuals with Smith-Magenis syndrome have the disorder as a result of an interstitial 17p11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, which may have been previously excluded by <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> testing.</p></div></dd><dt>2. </dt><dd><div id="kleefstra.TF.2.2"><p class="no_margin">The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic mechanism leading to the loss of UBE3A function.</p></div></dd><dt>3. </dt><dd><div id="kleefstra.TF.2.3"><p class="no_margin">Facial features that differentiate Kleefstra syndrome from Angelman syndrome include synophrys and everted vermilion of the lower lip. Some mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with Kleefstra syndrome have a &#x02265;100-word vocabulary &#x00026; speak in sentences, which would be very unusual in an individual with Angelman syndrome.</p></div></dd><dt>4. </dt><dd><div id="kleefstra.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#kleefstra.REF.koemans.2017.e1006864">Koemans et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="kleefstra.TF.2.5"><p class="no_margin">The diagnosis of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with one of the following: <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 2q23.1 that encompasses all or part of <i>MBD5</i> (~90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals); intragenic deletion involving one or more exons of <i>MBD5</i> (~5%); a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic sequence variant in <i>MBD5</i> (~5%); or, rarely, an apparently balanced complex <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement of the 2q23.1 region involving <i>MBD5</i>.</p></div></dd></dl></div></div></div></div><div id="kleefstra.Management"><h2 id="_kleefstra_Management_">Management</h2><div id="kleefstra.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Kleefstra syndrome, the evaluations summarized in <a class="figpopup" href="/books/NBK47079/table/kleefstra.T.recommended_evaluations_foll/?report=objectonly" target="object" rid-figpopup="figkleefstraTrecommendedevaluationsfoll" rid-ob="figobkleefstraTrecommendedevaluationsfoll">Table 3</a> (if not performed as part of the evaluation that led to diagnosis) are recommended.</p><div id="kleefstra.T.recommended_evaluations_foll" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Kleefstra Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47079/table/kleefstra.T.recommended_evaluations_foll/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kleefstra.T.recommended_evaluations_foll_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Weight, height, &#x00026; body mass index (in those age &#x0003e;2 yrs)</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to nutritionist in those w/obesity.</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dental evaluation</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess for dental issues, incl retention of primary dentition</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess for refractive errors</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ears</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiologic evaluation</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess for hearing loss</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Echocardiogram &#x00026; electrocardiogram</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for structural heart defects &#x00026; rhythm disturbance; consider referral to cardiologist.</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for history of sleep disturbance.</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to a sleep disorders clinic.</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Feeding</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for signs &#x00026; symptoms of gastroesophageal reflux disease.</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Renal ultrasound</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for structural renal anomalies &#x00026; hydronephrosis</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to neurologist.</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">EEG</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If seizures are suspected</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Head MRI</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If seizures &#x00026;/or movement disorder, extreme apathy/catatonia, &#x00026;/or regression in psychomotor development is present</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric/</b><br /><b>Behavioral</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropsychiatric evaluation</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Screen individuals age &#x0003e;12 mos for behavior concerns incl sleep disturbances, mood problems, psychotic disorders, anxiety, &#x00026;/or traits suggestive of ASD.</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate motor, speech/language, general cognitive, &#x00026; vocational skills.</td></tr><tr><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_kleefstra.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ASD = autism spectrum disorder</p></div></dd></dl></div></div></div></div><div id="kleefstra.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is primarily supportive. Ongoing routine pediatric care by a pediatrician or neurologist, psychiatrist, and/or (for adults) specialist in the care of adults with intellectual disability is recommended.</p><div id="kleefstra.T.treatment_of_manifestations" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Kleefstra Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47079/table/kleefstra.T.treatment_of_manifestations/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kleefstra.T.treatment_of_manifestations_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Refractive error</b></td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment</td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Auditory amplification as appropriate</td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>.</td></tr><tr><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Congenital heart defects &#x00026; rhythm disturbance</b></td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per cardiologist</td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Sleep disturbance</b></td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment</td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No well-controlled treatment trials have been reported.</td></tr><tr><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastroesophageal reflux disease</b></td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment</td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to gastroenterologist for those w/severe issues.</td></tr><tr><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal anomalies</b></td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment</td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to urologist &#x00026;/or nephrologist.</td></tr><tr><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment w/AEDs by experienced neurologist&#x000a0;<sup>1</sup></td><td headers="hd_h_kleefstra.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Many different AEDs may be effective; no one AED has been demonstrated effective specifically for this disorder.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AEDs = antiepileptic drugs</p></div></dd><dt>1. </dt><dd><div id="kleefstra.TF.4.1"><p class="no_margin">Education of parents regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</p></div></dd></dl></div></div></div><div id="kleefstra.Developmental_Delay__Intellect"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="kleefstra.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li><li class="half_rhythm"><div>For muscle tone abnormalities including hypertonia or dystonia, consider involving appropriate specialists to aid in management of baclofen, Botox<sup>&#x000ae;</sup>, anti-parkinsonian medications, or orthopedic procedures.</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="kleefstra.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications when necessary.</p><p>Specialized neurologic and psychiatric care is advised for individuals with extreme behavior problems and/or movement disorder. Behavioral therapies include special education techniques that may help minimize behavioral outbursts in the school setting by emphasizing individualized instruction, structure, and a set daily routine.</p></div></div><div id="kleefstra.Surveillance"><h3>Surveillance</h3><p>Cardiac and renal/urologic abnormalities should be monitored as needed.</p></div><div id="kleefstra.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#kleefstra.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="kleefstra.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="kleefstra.Genetic_Counseling"><h2 id="_kleefstra_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="kleefstra.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Kleefstra syndrome, caused by a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at 9q34.3 or an intragenic <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner; almost all cases reported to date have been <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</p></div><div id="kleefstra.Risk_to_Family_Members"><h3>Risk to Family Members</h3><div id="kleefstra.9q34_3_Deletion"><h4>9q34.3 Deletion</h4><p>9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is usually <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> but may be inherited as the result of a complex chromosomal rearrangement or <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in a parent.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>To date, no parent-to-child transmission of an unbalanced derivative <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> involving the 9q34.3 region has been observed.</div></li><li class="half_rhythm"><div>Recurrence in families with a parent having a balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> involving the 9q34.3 region has been described [<a class="bk_pop" href="#kleefstra.REF.knight.1999.1676">Knight et al 1999</a>, <a class="bk_pop" href="#kleefstra.REF.dawson.2002.488">Dawson et al 2002</a>].</div></li><li class="half_rhythm"><div>To date, all interstitial 9q34.3 deletions detected are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, except for three families in which one of the parents was shown to have a somatic mosaic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>. In one family, a parent with learning difficulties had two severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children; in another family, a parent with learning difficulties had one affected child [<a class="bk_pop" href="#kleefstra.REF.willemsen.2011.31">Willemsen et al 2011</a>, <a class="bk_pop" href="#kleefstra.REF.de_boer.2018.5">de Boer et al 2018</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of asymptomatic parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> include routine karyotyping with additional <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis to determine if a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement involving the 9q34.3 region is present.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the parents.</div></li><li class="half_rhythm"><div>In the (unlikely) event that a parent has either <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for a 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, low-level <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> that includes the germline, or a balanced structural <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement involving the 9q34.3 region, the risk to sibs is increased. The estimated risk depends on the specific chromosome rearrangement.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>To date, five individuals diagnosed with a mosaic 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have been known to reproduce [<a class="bk_pop" href="#kleefstra.REF.willemsen.2011.31">Willemsen et al 2011</a>, <a class="bk_pop" href="#kleefstra.REF.de_boer.2018.5">de Boer et al 2018</a>].</div></li><li class="half_rhythm"><div>Individuals who have the 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> would be expected to have a 50% chance of transmitting the deletion to each child.</div></li></ul></div><div id="kleefstra.EHMT1_Pathogenic_Variant"><h4><i>EHMT1</i> Pathogenic Variant</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>In the vast majority of cases, <i>EHMT1</i> pathogenic variants have occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>. All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in the family).</div></li><li class="half_rhythm"><div>To date, only one parent of an individual with an <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has also had the pathogenic variant, although it was a mosaic pathogenic variant in an unaffected parent [<a class="bk_pop" href="#kleefstra.REF.rump.2013.887">Rump et al 2013</a>].</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the pathogenic variant most likely occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the proband. Another possible explanation is that the proband inherited a pathogenic variant from a parent with <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#kleefstra.REF.rump.2013.887">Rump et al 2013</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the parents.</div></li><li class="half_rhythm"><div>In the (unlikely) event that a parent has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> or low-level <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for an <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that also includes the germline, the risk to sibs is increased.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>No individual with a non-mosaic <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been known to reproduce.</div></li><li class="half_rhythm"><div>Individuals who have a non-mosaic <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> would be expected to have a 50% chance of transmitting the pathogenic variant to each child.</div></li></ul></div></div><div id="kleefstra.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who may be at risk of having a child with Kleefstra syndrome.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="kleefstra.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Prenatal testing for at-risk pregnancies and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> require prior identification of the 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or an <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and/or of balanced <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status in a parent. Prenatal testing may be offered to unaffected parents who have had a child with a 9q34.3 deletion or an <i>EHMT1</i> pathogenic variant because of the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> associated with the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> including the germline, or a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>.</p><p><b>Pregnancies not known to be at increased risk for the 9q34.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</b> CMA performed in a pregnancy not known to be at increased risk may detect the 9q34.3 deletion [<a class="bk_pop" href="#kleefstra.REF.guterman.2018.570">Guterman et al 2018</a>].</p></div></div><div id="kleefstra.Resources"><h2 id="_kleefstra_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Chromosome Disorder Outreach (CDO)</b></div><div>PO Box 724</div><div>Boca Raton FL 33429-0724</div><div><b>Phone:</b> 561-395-4252 (Family Helpline)</div><div><b>Email:</b> info@chromodisorder.org</div><div><a href="http://www.chromodisorder.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.chromodisorder.org</a></div></li><li class="half_rhythm"><div><b>Unique: The Rare Chromosome Disorder Support Group</b></div><div>G1 The Stables</div><div>Station Road West</div><div>Oxted Surrey RH8 9EE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 1883 723356</div><div><b>Email:</b> info@rarechromo.org; rarechromo@aol.com</div><div><a href="http://www.rarechromo.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rarechromo.org</a></div></li></ul></div><div id="kleefstra.Molecular_Genetics"><h2 id="_kleefstra_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="kleefstra.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Kleefstra Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47079/table/kleefstra.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kleefstra.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_kleefstra.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_kleefstra.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_kleefstra.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_kleefstra.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_kleefstra.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_kleefstra.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_kleefstra.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/79813" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EHMT1</i></a></td><td headers="hd_b_kleefstra.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=79813" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q34<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kleefstra.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9H9B1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Histone-lysine N-methyltransferase EHMT1</a></td><td headers="hd_b_kleefstra.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/EHMT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EHMT1 database</a></td><td headers="hd_b_kleefstra.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EHMT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EHMT1</a></td><td headers="hd_b_kleefstra.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EHMT1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EHMT1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="kleefstra.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="kleefstra.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Kleefstra Syndrome (<a href="/omim/607001,610253" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47079/table/kleefstra.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kleefstra.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607001" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607001</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EUCHROMATIC HISTONE METHYLTRANSFERASE 1; EHMT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610253" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610253</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KLEEFSTRA SYNDROME 1; KLEFS1</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The previously defined <i>EHMT1</i> transcript (<a href="/nuccore/40217807" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024757.3</a>) contained 26 exons, the translation start site being located in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2. The "updated" <a href="/nuccore/NM_024757.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024757.4</a> version varies significantly and contains an extra 5' exon. The novel <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> comprises 27 coding exons. The translation start site is located in the "novel" exon 1, 97.6 kb proximal to the "old" ATG start codon. Diagnostic testing so far has been directed towards the 25 coding exons of the <i>EHMT1</i> NM_024757.3 sequence. Since three individuals with Kleefstra syndrome harbor interstitial 9q deletions encompassing only this novel <i>EHMT1</i> sequence in addition to several proximally located genes [Author, personal observation], routine diagnostic testing should be adjusted to the novel transcript. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK47079/#kleefstra.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<i>EHMT1</i> sequence variants include <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and small deletions and duplications [<a class="bk_pop" href="#kleefstra.REF.kleefstra.2006a.370">Kleefstra et al 2006a</a>, <a class="bk_pop" href="#kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</a>, <a class="bk_pop" href="#kleefstra.REF.willemsen.2012.202">Willemsen et al 2012</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a href="/nuccore/NM_024757.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024757.4</a> transcript encodes euchromatin histone-lysine N-methyl transferase 1, a protein of 1,298 amino acid residues involved in histone <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a>. DNA is wrapped around histones, and histone tails have an important role in folding of chromatin fibers. Methylation of these histone tails is thought to regulate this folding process, thereby altering the accessibility of DNA to proteins mediating transcription [<a class="bk_pop" href="#kleefstra.REF.martin.2005.838">Martin &#x00026; Zhang 2005</a>]. The restricted expression of <i>EHMT1</i> in the mouse brain (olfactory bulb, the anterior/ventral ventricular wall, hippocampus, and piriform cortex) supports a role of epigenetic histone modification in normal brain development [<a class="bk_pop" href="#kleefstra.REF.kleefstra.2005.299">Kleefstra et al 2005</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Haploinsufficiency resulting from <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or inactivation of one <i>EHMT1</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is the cause of Kleefstra syndrome. The majority of pathogenic variants disrupt the <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> of <i>EHMT1</i> and are predicted to lead to <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated decay. The one pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant described to date is predicted to have an influence on the local conformation of the pre-SET <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the EHMT1 protein, thereby reflecting a <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> allele [<a class="bk_pop" href="#kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</a>]. Besides <i>EHMT1</i>, other genes associated with intellectual disability (e.g., <i>MECP2</i>, <i>RSK2</i>, and <i>XNP</i>) appear to play a role in chromatin remodeling [<a class="bk_pop" href="#kleefstra.REF.ausi_.2003.83">Ausi&#x000f3; et al 2003</a>]. Loss of proper regulation of chromatin structure can result in deregulation of gene transcription and inappropriate protein expression. This can in turn contribute to complex genetic disorders including intellectual disability.</p></div><div id="kleefstra.References"><h2 id="_kleefstra_References_">References</h2><div id="kleefstra.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.ausi_.2003.83">Ausi&#x000f3; J, Levin DB, de Amorim GV, Bakker S, MacLeod PM. Syndromes of disordered chromatin remodeling. <span><span class="ref-journal">Clin Genet. </span>2003;<span class="ref-vol">64</span>:83–95.</span> [<a href="/pubmed/12859401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12859401</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.bock.2016.131">Bock I, N&#x000e9;meth K, Pentel&#x000e9;nyi K, Balicza P, Bal&#x000e1;zs A, Moln&#x000e1;r MJ, Rom&#x000e1;n V, Nagy J, L&#x000e9;vay G, Kobol&#x000e1;k J, Dinny&#x000e9;s A. Targeted next generation sequencing of a panel of autism-related genes identifies an EHMT1 mutation in a Kleefstra syndrome patient with autism and normal intellectual performance. <span><span class="ref-journal">Gene. </span>2016;<span class="ref-vol">595</span>:131–41.</span> [<a href="/pubmed/27651234" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27651234</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.cormierdaire.2003.300">Cormier-Daire V, Molinari F, Rio M, Raoul O, de Blois MC, Romana S, Vekemans M, Munnich A, Colleaux L. Cryptic terminal deletion of chromosome 9q34: a novel cause of syndromic obesity in childhood? <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:300–3.</span> [<a href="/pmc/articles/PMC1735435/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735435</span></a>] [<a href="/pubmed/12676904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12676904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.dawson.2002.488">Dawson AJ, Putnam S, Schultz J, Riordan D, Prasad C, Greenberg CR, Chodirker BN, Mhanni AA, Chudley AE. Cryptic chromosome rearrangements detected by subtelomere assay in patients with mental retardation and dysmorphic features. <span><span class="ref-journal">Clin Genet. </span>2002;<span class="ref-vol">62</span>:488–94.</span> [<a href="/pubmed/12515261" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12515261</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.de_boer.2018.5">de Boer A, Vermeulen K, Egger JIM, Janzing JGE, de Leeuw N, Veenstra-Knol HE, den Hollander NS, van Bokhoven H, Staal W, Kleefstra T. <em>EHMT1</em> mosaicism in apparently unaffected parents is associated with autism spectrum disorder and neurocognitive dysfunction. <span><span class="ref-journal">Mol Autism. </span>2018;<span class="ref-vol">9</span>:5.</span> [<a href="/pmc/articles/PMC5784506/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5784506</span></a>] [<a href="/pubmed/29416845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29416845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.guterman.2018.570">Guterman S, Herv&#x000e9; B, Rivi&#x000e8;re J, Fauvert D, Clement P, Vialard F. First prenatal diagnosis of a 'pure' 9q34.3 deletion (Kleefstra syndrome): a case report and literature review. <span><span class="ref-journal">J Obstet Gynaecol Res. </span>2018;<span class="ref-vol">44</span>:570–5.</span> [<a href="/pubmed/29160022" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29160022</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.kleefstra.2006a.370">Kleefstra T, Brunner HG, Amiel J, Oudakker AR, Nillesen WM, Magee A, Genevi&#x000e8;ve D, Cormier-Daire V, van Esch H, Fryns JP, Hamel BC, Sistermans EA, de Vries BB, van Bokhoven H. Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2006a;<span class="ref-vol">79</span>:370–7.</span> [<a href="/pmc/articles/PMC1559478/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1559478</span></a>] [<a href="/pubmed/16826528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16826528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.kleefstra.2006b.618">Kleefstra T, Koolen DA, Nillesen WM, de Leeuw N, Hamel BC, Veltman JA, Sistermans EA, van Bokhoven H, van Ravenswaay C, de Vries BB. Interstitial 2.2 Mb deletion at 9q34 in a patient with mental retardation but without classical features of the 9q subtelomeric deletion syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2006b;<span class="ref-vol">140</span>:618–23.</span> [<a href="/pubmed/16470689" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16470689</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.kleefstra.2005.299">Kleefstra T, Smidt M, Banning MJ, Oudakker AR, Van Esch H, de Brouwer AP, Nillesen W, Sistermans EA, Hamel BC, de Bruijn D, et al.  Disruption of the gene euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:299–306.</span> [<a href="/pmc/articles/PMC1736026/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736026</span></a>] [<a href="/pubmed/15805155" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15805155</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.kleefstra.2009.598">Kleefstra T, van Zelst-Stams WA, Nillesen WM, Cormier-Daire V, Houge G, Foulds N, van Dooren M, Willemsen MH, Pfundt R, Turner A, Wilson M, McGaughran J, Rauch A, Zenker M, Adam MP, Innes M, Davies C, L&#x000f3;pez AG, Casalone R, Weber A, Brueton LA, Navarro AD, Bralo MP, Venselaar H, Stegmann SP, Yntema HG, van Bokhoven H, Brunner HG. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:598–606.</span> [<a href="/pubmed/19264732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19264732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.knight.1999.1676">Knight SJ, Regan R, Nicod A, Horsley SW, Kearney L, Homfray T, Winter RM, Bolton P, Flint J. Subtle chromosomal rearrangements in children with unexplained mental retardation. <span><span class="ref-journal">Lancet. </span>1999;<span class="ref-vol">354</span>:1676–81.</span> [<a href="/pubmed/10568569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10568569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.koemans.2017.e1006864">Koemans TS, Kleefstra T, Chubak MC, Stone MH, Reijnders MRF, de Munnik S, Willemsen MH, Fenckova M, Stumpel CTRM, Bok LA, Sifuentes Saenz M, Byerly KA, Baughn LB, Stegmann APA, Pfundt R, Zhou H, van Bokhoven H, Schenck A, Kramer JM. Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder. <span><span class="ref-journal">PLoS Genet. </span>2017;<span class="ref-vol">13</span>:e1006864.</span> [<a href="/pmc/articles/PMC5656305/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5656305</span></a>] [<a href="/pubmed/29069077" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29069077</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.martin.2005.838">Martin C, Zhang Y. The diverse functions of histone lysine methylation. <span><span class="ref-journal">Nat Rev Mol Cell Biol. </span>2005;<span class="ref-vol">6</span>:838–49.</span> [<a href="/pubmed/16261189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16261189</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.mcrae.2017.433">McRae JF, Clayton S, Fitzgerald TW, Kaplanis J, Prigmore E, Rajan D, Sifrim A, Aitken S, Akawi N, Alvi M, et al.  Prevalence and architecture of de novo mutations in developmental disorders. <span><span class="ref-journal">Nature. </span>2017;<span class="ref-vol">542</span>:433–8.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.rump.2013.887">Rump A, Hildebrand L, Tzschach A, Ullmann R, Schrock E, Mitter D. A mosaic maternal splice donor mutation in the EHMT1 gene leads to aberrant transcripts and to Kleefstra syndrome in the offspring. <span><span class="ref-journal">Eur J Hum Genet. </span>2013;<span class="ref-vol">21</span>:887–90.</span> [<a href="/pmc/articles/PMC3722677/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3722677</span></a>] [<a href="/pubmed/23232695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23232695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.stewart.2004.340">Stewart DR, Huang A, Faravelli F, Anderlid BM, Medne L, Ciprero K, Kaur M, Rossi E, Tenconi R, Nordenskj&#x000f6;ld M, Gripp KW, Nicholson L, Meschino WS, Capua E, Quarrell OW, Flint J, Irons M, Giampietro PF, Schowalter DB, Zaleski CA, Malacarne M, Zackai EH, Spinner NB, Krantz ID. Subtelomeric deletions of chromosome 9q: a novel microdeletion syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">128A</span>:340–51.</span> [<a href="/pubmed/15264279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15264279</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.stewart.2007.383">Stewart DR, Kleefstra T. The chromosome 9q subtelomere deletion syndrome. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2007;<span class="ref-vol">145C</span>:383–92.</span> [<a href="/pubmed/17910072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17910072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.verhoeven.2010.536">Verhoeven WM, Kleefstra T, Egger JI. Behavioral phenotype in the 9q subtelomeric deletion syndrome: a report about two adult patients. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2010;<span class="ref-vol">153B</span>:536–41.</span> [<a href="/pubmed/19642112" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19642112</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.vermeulen.2017a.1821">Vermeulen K, de Boer A, Janzing JGE, Koolen DA, Ockeloen CW, Willemsen MH, Verhoef FM, van Deurzen PAM, van Dongen L, van Bokhoven H, Egger JIM, Staal WG, Kleefstra T. Adaptive and maladaptive functioning in Kleefstra syndrome compared to other rare genetic disorders with intellectual disabilities. <span><span class="ref-journal">Am J Med Genet A. </span>2017a;<span class="ref-vol">173</span>:1821–30.</span> [<a href="/pubmed/28498556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28498556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.vermeulen.2017b.185">Vermeulen K, Staal WG, Janzing JG, van Bokhoven H, Egger JIM, Kleefstra T. Sleep disturbance as a precursor of severe regression in Kleefstra syndrome suggests a need for firm and rapid pharmacological treatment. <span><span class="ref-journal">Clin Neuropharmacol. </span>2017b;<span class="ref-vol">40</span>:185–8.</span> [<a href="/pubmed/28622207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28622207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.willemsen.2011.31">Willemsen MH, Beunders G, Callaghan M, de Leeuw N, Nillesen WM, Yntema HG, van Hagen JM, Nieuwint AW, Morrison N, Keijzers-Vloet ST, Hoischen A, Brunner HG, Tolmie J, Kleefstra T. Familial Kleefstra syndrome due to maternal somatic mosaicism for interstitial 9q34.3 microdeletions. <span><span class="ref-journal">Clin Genet. </span>2011;<span class="ref-vol">80</span>:31–8.</span> [<a href="/pubmed/21204793" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21204793</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.willemsen.2012.202">Willemsen MH, Vulto-van Silfhout AT, Nillesen WM, Wissink-Lindhout WM, van Bokhoven H, Philip N, Berry-Kravis EM, Kini U, van Ravenswaaij-Arts CM, Delle Chiaie B, Innes AM, Houge G, Kosonen T, Cremer K, Fannemel M, Stray-Pedersen A, Reardon W, Ignatius J, Lachlan K, Mircher C, Helderman van den Enden PT, Mastebroek M, Cohn-Hokke PE, Yntema HG, Drunat S, Kleefstra T. Update on Kleefstra syndrome. <span><span class="ref-journal">Mol Syndromol. </span>2012;<span class="ref-vol">2</span>:202–12.</span> [<a href="/pmc/articles/PMC3366700/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3366700</span></a>] [<a href="/pubmed/22670141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22670141</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.yatsenko.2009.1924">Yatsenko SA, Brundage EK, Roney EK, Cheung SW, Chinault AC, Lupski JR. Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:1924–36.</span> [<a href="/pmc/articles/PMC2678925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2678925</span></a>] [<a href="/pubmed/19293338" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19293338</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kleefstra.REF.yatsenko.2005.328">Yatsenko SA, Cheung SW, Scott DA, Nowaczyk MJ, Tarnopolsky M, Naidu S, Bibat G, Patel A, Leroy JG, Scaglia F, et al.  Deletion 9q34.3 syndrome: genotype-phenotype correlations and an extended deletion in a patient with features of Opitz C trigonocephaly. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:328–35.</span> [<a href="/pmc/articles/PMC1736036/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736036</span></a>] [<a href="/pubmed/15805160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15805160</span></a>]</div></li></ul></div></div><div id="kleefstra.Chapter_Notes"><h2 id="_kleefstra_Chapter_Notes_">Chapter Notes</h2><div id="kleefstra.Author_History"><h3>Author History</h3><p>Nicole de Leeuw, PhD (2019-present)<br />Tjitske Kleefstra, MD, PhD (2010-present)<br />Willy M Nillesen, BSc; Radboud University Medical Center (2010-2019)<br />Helger G Yntema, PhD; Radboud University Medical Center (2010-2019)</p></div><div id="kleefstra.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 March 2019 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 May 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 October 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>28 May 2010 (tk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK47079</span><span class="label">PMID: <a href="/pubmed/20945554" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20945554</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kindler/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mdel17q21_31/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK47079&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK47079/?report=reader">PubReader</a></li><li><a href="/books/NBK47079/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK47079" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK47079" style="display:none" title="Cite this Page"><div class="bk_tt">Kleefstra T, de Leeuw N. Kleefstra Syndrome. 2010 Oct 5 [Updated 2019 Mar 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK47079/pdf/Bookshelf_NBK47079.pdf">PDF version of this page</a> (1.0M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#kleefstra.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#kleefstra.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#kleefstra.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#kleefstra.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#kleefstra.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#kleefstra.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#kleefstra.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#kleefstra.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#kleefstra.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#kleefstra.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#kleefstra.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79813[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EHMT1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK47079+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2336440" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2336440" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2336440" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2336440" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301487" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Smith ACM, Boyd KE, Brennan C, Charles J, Elsea SH, Finucane BM, Foster R, Gropman A, Girirajan S, Haas-Givler B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30063093" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Pulmonary hypertension in patients with 9q34.3 microdeletion-associated Kleefstra syndrome.</a><span class="source">[Am J Med Genet A. 2018]</span><div class="brieflinkpop offscreen_noflow">Pulmonary hypertension in patients with 9q34.3 microdeletion-associated Kleefstra syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Okur V, Nees S, Chung WK, Krishnan U. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2018 Aug; 176(8):1773-1777. Epub 2018 Jul 31.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28057753" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A Novel Kleefstra Syndrome-associated Variant That Affects the Conserved TPL&lt;i&gt;X&lt;/i&gt; Motif within the Ankyrin Repeat of EHMT1 Leads to Abnormal Protein Folding.</a><span class="source">[J Biol Chem. 2017]</span><div class="brieflinkpop offscreen_noflow">A Novel Kleefstra Syndrome-associated Variant That Affects the Conserved TPL&lt;i&gt;X&lt;/i&gt; Motif within the Ankyrin Repeat of EHMT1 Leads to Abnormal Protein Folding.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Blackburn PR, Tischer A, Zimmermann MT, Kemppainen JL, Sastry S, Knight Johnson AE, Cousin MA, Boczek NJ, Oliver G, Misra VK, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Biol Chem. 2017 Mar 3; 292(9):3866-3876. Epub 2017 Jan 5.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25380126" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Severe neonatal presentation of Kleefstra syndrome in a patient with hypoplastic left heart syndrome and 9q34.3 microdeletion.</a><span class="source">[Birth Defects Res A Clin Mol T...]</span><div class="brieflinkpop offscreen_noflow">Severe neonatal presentation of Kleefstra syndrome in a patient with hypoplastic left heart syndrome and 9q34.3 microdeletion.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Campbell CL, Collins RT 2nd, Zarate YA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Birth Defects Res A Clin Mol Teratol. 2014 Dec; 100(12):985-90. Epub 2014 Nov 7.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301783" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Koolen-de Vries Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Koolen-de Vries Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Koolen DA, Morgan A, de Vries BBA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20945554" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20945554" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04199fdde0891169507e52">Kleefstra Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Kleefstra Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:23:28-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BF05CE0418F2100000000004E0022&amp;ncbi_session=CE8BF05CE04199F1_0078SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK47079%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK47079&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK47079/&amp;ncbi_pagename=Kleefstra Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BF05CE04199F1_0078SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>